Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Retained Earnings: 2021-2022

Historic Retained Earnings for Milestone Pharmaceuticals (MIST) over the last 2 years, with Sep 2022 value amounting to -$251.5 million.

  • Milestone Pharmaceuticals' Retained Earnings fell 32.78% to -$251.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$251.5 million, marking a year-over-year decrease of 32.78%. This contributed to the annual value of -$208.0 million for FY2021, which is N/A change from last year.
  • As of Q3 2022, Milestone Pharmaceuticals' Retained Earnings stood at -$251.5 million, which was down 6.13% from -$237.0 million recorded in Q2 2022.
  • Over the past 5 years, Milestone Pharmaceuticals' Retained Earnings peaked at -$175.2 million during Q2 2021, and registered a low of -$251.5 million during Q3 2022.
  • For the 2-year period, Milestone Pharmaceuticals' Retained Earnings averaged around -$208.2 million, with its median value being -$208.0 million (2021).
  • Data for Milestone Pharmaceuticals' Retained Earnings shows a maximum YoY plummeted of 35.27% (in 2022) over the last 5 years.
  • Milestone Pharmaceuticals' Retained Earnings (Quarterly) stood at -$208.0 million in 2021, then tumbled by 32.78% to -$251.5 million in 2022.
  • Its Retained Earnings was -$251.5 million in Q3 2022, compared to -$237.0 million in Q2 2022 and -$220.3 million in Q1 2022.